BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30915086)

  • 1. Altered Immunity and Microbial Dysbiosis in Aged Individuals With Long-Term Controlled HIV Infection.
    Rhoades N; Mendoza N; Jankeel A; Sureshchandra S; Alvarez AD; Doratt B; Heidari O; Hagan R; Brown B; Scheibel S; Marbley T; Taylor J; Messaoudi I
    Front Immunol; 2019; 10():463. PubMed ID: 30915086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated with Aging, HIV Load, CD4 Count, and Antiretroviral Therapy.
    Lewy T; Hong BY; Weiser B; Burger H; Tremain A; Weinstock G; Anastos K; George MD
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):276-286. PubMed ID: 29808701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients.
    Pinacchio C; Scagnolari C; Iebba V; Santinelli L; Innocenti GP; Frasca F; Bitossi C; Scordio M; Oliveto G; Ceccarelli G; Antonelli G; Mastroianni CM; d'Ettorre G
    AIDS; 2020 Aug; 34(10):1467-1473. PubMed ID: 32675560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals.
    Xie Y; Sun J; Wei L; Jiang H; Hu C; Yang J; Huang Y; Ruan B; Zhu B
    BMC Microbiol; 2021 Jan; 21(1):11. PubMed ID: 33407128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection.
    Dillon SM; Lee EJ; Kotter CV; Austin GL; Gianella S; Siewe B; Smith DM; Landay AL; McManus MC; Robertson CE; Frank DN; McCarter MD; Wilson CC
    Mucosal Immunol; 2016 Jan; 9(1):24-37. PubMed ID: 25921339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
    Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.
    Ishizaka A; Koga M; Mizutani T; Parbie PK; Prawisuda D; Yusa N; Sedohara A; Kikuchi T; Ikeuchi K; Adachi E; Koibuchi T; Furukawa Y; Tojo A; Imoto S; Suzuki Y; Tsutsumi T; Kiyono H; Matano T; Yotsuyanagi H
    Microbiol Spectr; 2021 Sep; 9(1):e0070821. PubMed ID: 34378948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
    Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S
    Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort.
    Kapogiannis BG; Henderson SL; Nigam P; Sharma S; Chennareddi L; Herndon JG; Robinson HL; Amara RR
    AIDS Res Hum Retroviruses; 2006 Mar; 22(3):272-82. PubMed ID: 16545014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Low Frequency of IL-17-Producing CD8
    Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
    Front Immunol; 2018; 9():2502. PubMed ID: 30420859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV DNA and immune alteration during successful HAART.
    Mamadou D; Yu-Huang Z; Xia C; Bo H; Hua-Ying Z; Yan H; Zi C; Qing L; Li-Wen Z; Mei H; Yun-Hai Y; Demba S; Aldebert D; Souleymane M
    Curr HIV Res; 2013 Jun; 11(4):255-62. PubMed ID: 23822818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
    Lichtenstein KA; Armon C; Nagabhushanam V; Efaw BJ; Frazer-Abel A; Hiserote ME; Alam R
    Antivir Ther; 2012; 17(7):1301-9. PubMed ID: 22948290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
    Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
    Jansen CA; Piriou E; De Cuyper IM; van Dort K; Lange JM; Miedema F; van Baarle D
    Antivir Ther; 2006; 11(1):105-16. PubMed ID: 16518966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution in HIV+ subjects on lopinavir/ritonavir-based HAART according to the severity of pre-therapy CD4+.
    Marchetti G; Merlini E; Sinigaglia E; Iannotti N; Bai F; Savoldi A; Tincati C; Carpani G; Bini T; Arminio Monforte A
    Curr HIV Res; 2012 Oct; 10(7):597-605. PubMed ID: 22716104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection.
    Guillén Y; Noguera-Julian M; Rivera J; Casadellà M; Zevin AS; Rocafort M; Parera M; Rodríguez C; Arumí M; Carrillo J; Mothe B; Estany C; Coll J; Bravo I; Herrero C; Saz J; Sirera G; Torrella A; Navarro J; Crespo M; Negredo E; Brander C; Blanco J; Calle ML; Klatt NR; Clotet B; Paredes R
    Mucosal Immunol; 2019 Jan; 12(1):232-246. PubMed ID: 30171206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
    Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
    J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA.
    Twizerimana AP; Mwatha J; Musabyimana JP; Kayigi E; Harelimana Jde D; Karanja SM; Mutesa L
    East Afr Med J; 2014 Aug; 91(8):261-6. PubMed ID: 26862650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
    Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
    AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+ DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    Immunol Lett; 2001 Mar; 76(2):69-78. PubMed ID: 11274723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.